2005
Atrial fibrillation: How to approach rate control
Rosenfeld LE. Atrial fibrillation: How to approach rate control. Current Cardiology Reports 2005, 7: 391-397. PMID: 16105496, DOI: 10.1007/s11886-005-0094-3.Commentaries, Editorials and LettersConceptsPrevention of tachycardiaRhythm control strategyMinority of patientsCalcium channel blockersReduction of symptomsUse of therapiesEvidence-based definitionConsiderable clinical importanceNodal ablationAtrial fibrillationSerial assessmentNovel therapiesChannel blockersΒ-blockersHeart rateClinical importanceOptimal managementTherapySymptomsRate controlTachycardiaPatientsCardiomyopathyFibrillationBlockers
2004
The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study Approaches to control rate in atrial fibrillation
Olshansky B, Rosenfeld LE, Warner AL, Solomon AJ, O'Neill G, Sharma A, Platia E, Feld GK, Akiyama T, Brodsky MA, Greene HL, Investigators A. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study Approaches to control rate in atrial fibrillation. Journal Of The American College Of Cardiology 2004, 43: 1201-1208. PMID: 15063430, DOI: 10.1016/j.jacc.2003.11.032.Peer-Reviewed Original ResearchMeSH KeywordsAdrenergic beta-AntagonistsAgedAnti-Arrhythmia AgentsAtrial FibrillationCalcium Channel BlockersCatheter AblationDigoxinDrug Therapy, CombinationElectrocardiography, AmbulatoryFemaleFollow-Up StudiesHeart RateHumansMaleMiddle AgedMultivariate AnalysisPacemaker, ArtificialStroke VolumeTreatment OutcomeConceptsCalcium channel blockersAtrial Fibrillation FollowAtrial fibrillationChannel blockersAFFIRM studyDrug classesFirst drugAdequate rate controlFirst drug classFrequent medication changesRhythm Management (AFFIRM) studyMajority of patientsBeta-adrenergic blockersRate control drugsElectrocardiographic resultsMedication changesWalk testInitial treatmentClinical variablesEfficacy criteriaDrug combinationsHeart rateEffective drugsPatientsMultivariate analysis
1998
Amiodarone Induced Pulmonary Fibrosis in Infancy
BOWERS P, FIELDS J, SCHWARTZ D, ROSENFELD L, NEHGME R. Amiodarone Induced Pulmonary Fibrosis in Infancy. Pacing And Clinical Electrophysiology 1998, 21: 1665-1667. PMID: 9725167, DOI: 10.1111/j.1540-8159.1998.tb00257.x.Peer-Reviewed Original ResearchConceptsInduced Pulmonary FibrosisPulmonary fibrosisDiffuse interstitial infiltratesPediatric age groupAtrioventricular reentrant tachycardiaPediatric arrhythmiasInterstitial infiltratesWolff-ParkinsonReentrant tachycardiaWhite syndromeChest radiographsFibrosisAge groupsAmiodaroneInfantsMonthsFirst reportInfiltratesComplicationsTachycardiaAntiarrhythmiaArrhythmiasSyndromeRadiographs
1992
Antiarrhythmic drug exacerbation of ventricular tachycardia inducibility during electrophysiologic study
Sager P, Perlmutter R, Rosenfeld L, Batsford W. Antiarrhythmic drug exacerbation of ventricular tachycardia inducibility during electrophysiologic study. American Heart Journal 1992, 123: 926-933. PMID: 1550002, DOI: 10.1016/0002-8703(92)90698-u.Peer-Reviewed Original ResearchConceptsTest-negative groupInducible ventricular tachycardiaTest positive groupVentricular tachycardiaElectrophysiologic studyVentricular arrhythmiasClinical characteristicsSignificant organic heart diseaseInducible sustained ventricular tachycardiaDrug-induced exacerbationGroups' clinical characteristicsInducible ventricular arrhythmiasDrug testsVentricular ejection fractionVentricular tachycardia inductionOrganic heart diseaseSustained ventricular tachycardiaBundle branch blockDrug-free stateVentricular tachycardia inducibilityTachycardia inductionAntiarrhythmic therapyInducible arrhythmiasEjection fractionVentricular aneurysm
1985
Day-to-day reproducibility of responses to right ventricular programmed electrical stimulation: Implications for serial drug testing
McPherson C, Rosenfeld L, Batsford W. Day-to-day reproducibility of responses to right ventricular programmed electrical stimulation: Implications for serial drug testing. The American Journal Of Cardiology 1985, 55: 689-695. PMID: 3976510, DOI: 10.1016/0002-9149(85)90138-9.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAnti-Arrhythmia AgentsCardiac Pacing, ArtificialElectric StimulationElectrophysiologyFemaleHeart VentriclesHumansMaleMiddle AgedTachycardiaTime FactorsConceptsVentricular tachycardiaVT inductionElectrical stimulationInduction of VTAntiarrhythmic drug therapySerial drug testingSecond control studySuch patientsPatient groupDrug therapyDay reproducibilityPatientsMore PEControl studyElectrical stimuliDrug testingStimulation modeBaseline stateStimulationTherapyInductionDaysFirst studyResponseTachycardia